The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
Year: 2016
Type: article
Source: Diabetologia
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Boehringer Ingelheim Fonds
Award: G4693328738
OpenAlex ID: W2555543235
